Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Leprosy relapse after multidrug therapy: Systematic review and meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis
10.3201/eid2907.230024 · 2023 · External reference
Unresolved reference
2020 · External reference
Global leprosy (Hansen disease) update, 2024: beyond zero cases – what elimination of leprosy really means
2025 · External reference
Unresolved reference
2017 · External reference
Unresolved reference
1988 · External reference
Unresolved reference
1994 · External reference
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
10.1371/journal.pntd.0005725 · 2017 · External reference
Retreatment of leprosy relapse
2005 · External reference
Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence
10.11124/jbisrir-2016-003301 · 2017 · External reference
Risk of relapse in leprosy after fixed-duration multidrug therapy
1997 · External reference
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses
1992 · External reference
Recidivas e reinfecção em hanseníase
10.11606/issn.2176-7262.v30i3p351-357 · 1997 · External reference
Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions
10.47276/lr.75.4.310 · 2004 · External reference
Unresolved reference
2015 · External reference
Retreatment in leprosy: a case-control study
10.1590/s0034-89102006005000037 · 2007 · External reference
Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach
10.1590/abd1806-4841.20186709 · 2018 · External reference
Características clínico-laboratoriais no retratamento por recidiva em hanseníase
10.1590/s1415-790x2012000300011 · 2012 · External reference
A guide to systematic review and meta-analysis
10.1186/s12874-021-01381-z · 2021 · External reference
Unresolved reference
External reference
How are systematic reviews of prevalence conducted? A methodological study
10.1186/s12874-020-00975-3 · 2020 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · External reference
Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study
2013 · External reference
Relapse in MB leprosy patients treated with 24 months of MDT in south west China: a short report
10.47276/lr.77.3.219 · 2006 · External reference
Relapses in multibacillary leprosy patients after multidrug therapy
10.47276/lr.79.3.320 · 2008 · External reference
Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis
10.1186/s13054-019-2489-3 · 2019 · External reference
Relapses in paucibacillary leprosy after MDT--a clinical study
1990 · External reference
Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi
1991 · External reference
Studies on risk of leprosy relapses in China: Relapses after treatment with multidrug therapy
1999 · External reference
Relapses in multibacillary leprosy patients: effect of length of therapy
2000 · External reference
Does there exist a subgroup of MB patients at greater risk of relapse after MDT?
2001 · External reference
Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients
10.1489/1544-581x(2003)071<0308:leoywm>2.0.co;2 · 2003 · External reference
A study on trend of relapse in leprosy and factors influencing relapse
2005 · External reference
Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines
10.4269/ajtmh.2009.09-0189 · 2009 · External reference
Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines
10.47276/lr.82.1.65 · 2011 · External reference
Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia
10.47276/lr.83.3.247 · 2012 · External reference
Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study
10.1136/bmjopen-2012-001403 · 2012 · External reference
Relapse and deformity among 2177 leprosy patients released from treatment with MDT between 2005 and 2010 in South India: A retrospective cohort study
10.47276/lr.86.4.345 · 2015 · External reference
Relapse in leprosy in post-elimination phase: scenario from a tertiary care center in South India
2017 · External reference
The Impact of Fixed Duration Multidrug Therapy on the Host and the Agent: A Pilot Study Using Clinical, Bacteriological, and Quality of Life Assessment Tools
2018 · External reference
Relapses in multibacillary (MB) and paucibacillary (PB) leprosy after treatment with standard multi-drug therapy (MDT): A retrospective analysis of patients attending leprosy clinic of a tertiary care hospital of northern India
2020 · External reference
Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug-resistance testing in leprosy?
10.1111/ced.14884 · 2022 · External reference
Low rate of relapse after twelve-dose multidrug therapy for hansen’s disease: A 20-year cohort study in a brazilian reference center
2021 · External reference
Low risk of relapse and deformity among leprosy patients who completed multi-drug therapy regimen from 2005 to 2010: A cohort study from four districts in South India
10.1371/journal.pntd.0009950 · 2021 · External reference
Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon
10.1093/cid/ciz570 · 2020 · External reference
Clinical and epidemiological characteristics of leprosy patients in the post elimination era: we need to be vigilant
2021 · External reference
Leprosy Relapse: A Retrospective Study on Epidemiologic, Clinical, and Therapeutic Aspects at a Brazilian Referral Center
10.1016/j.ijid.2022.01.009 · 2022 · External reference
Multidrug therapy for leprosy: a game changer on the path to elimination
10.1016/s1473-3099(17)30418-8 · 2017 · External reference
Leprosy: too complex a disease for a simple elimination paradigm
2005 · External reference
The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice
10.1084/jem.112.3.445 · 1960 · External reference
Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae
10.1371/journal.pntd.0002845 · 2014 · External reference
Global leprosy update, 2019: time to step-up prevention initiatives
2020 · External reference
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15
10.1016/j.cmi.2018.02.022 · 2018 · External reference
Risk factors for dapsone resistance in leprosy patients: a systematic meta-analysis
10.1016/j.jgar.2022.05.015 · 2022 · External reference
Unresolved reference
2024 · External reference
Prevention and Treatment of Leprosy — China, 2009−2019
10.46234/ccdcw2020.015 · 2020 · External reference
Prediction of leprosy in the Chinese population based on a weighted genetic risk score
10.1371/journal.pntd.0006789 · 2018 · External reference
High-risk spatiotemporal patterns of leprosy in the southeastern region of Yunnan province from 2010 to 2022: an analysis at the township level
10.1186/s12889-024-20182-9 · 2024 · External reference
Unresolved reference
1994 · External reference
Leprosy: epidemiological situation, treatment and control perspectives
2009 · External reference
Leprosy among patient contacts: a multilevel study of risk factors
10.1371/journal.pntd.0001013 · 2011 · External reference
Trends in leprosy case detection worldwide since 1985
10.47276/lr.75.1.19 · 2004 · External reference
Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group
1995 · External reference
Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients
10.1489/1544-581x(2003)071<0308:leoywm>2.0.co;2 · 2003 · External reference
Late relapses in leprosy patients: A retrospective study of 19 cases in an endemic region of the Brazilian Amazon
2024 · External reference
Unresolved reference
External reference
Genotyping of Mycobacterium leprae for understanding leprosy transmission in China
2020 · External reference
